Every year, top-ranking doctors in the New York area are recognized for exceptional treatment and quality care by being named America’s Top Doctors. This year, more than 15 surgeons from Columbia’s Department of Surgery were recognized for their skill and dedication in this year’s Top Doctors feature in New York Magazine.
20 surgeons from Columbia University have been named as 2019 Super Doctors, according to this year’s Super Doctors listings published with the New York Times Magazine. These rankings are compiled from thousands of recommendations by physicians in the New York area and represent approximately 5% of the area’s physicians.
New markers found in cancer-associated cells could make it easier for doctors to treat breast cancer, results of a new study published in Cancer Cell suggest. These new types of identifiers will help target chemotherapy by allowing doctors to better differentiate between healthy/normal tissue and cells contributing to cancer.
Starting April 29, 2019, three of Columbia’s pediatric surgeons will be holding office hours for patients in the Westchester area. These providers will be able to visit with patients and their parents for consultations and follow-up care at the ColumbiaDoctors Children’s Health office on North Broadway in White Plains.
Liver donation is a gift of life. For irreversible liver diseases—like cirrhosis and hepatitis, but also congenital diseases present at birth—liver donation can be life-saving. While the results of liver transplantation can be miraculous and curative, equally astonishing is that successful transplantation can occur using just a portion of the donor liver.
The impact of the results from low-risk TAVR trials will be felt for many years. It will be felt by a wide group - surgeons, cardiologists, hospital systems, insurance companies, and most importantly patients.
It was 8 am on a Thursday, and Nicholas Morrissey, MD, had already completed a proper morning. He taught residents from 6:15-7, attended a conference from 7-7:30, then met with his first patient in pre-op.
While it’s been around for years, TAVR was initially used as a last-chance option for people with highly severe aortic disease who wouldn’t be healthy enough to endure the intensity of a traditional surgery
The Columbia Pancreas Center is delighted to announce that our medical oncologist Gulam Manji, MD has been named the director of the newly established Pancreas Medical Oncology and Translational Research program.
